Capabilities
Strategic Advisory
Restructuring & Recapitalization
Independent Board Advice
Special Committee
Shareholder Activism
Capital Advisory
Transactions
Our Team
Careers
Community
Contact Us
Special Committee
Skip Navigation Links
strategic advisory
restructuring & recapitalization
independent board advice
special committee
shareholder activism
capital advisory
Centerview is the leading advisor to independent directors and special committees, having advised on more large-scale special committee transactions than any other financial advisor in recent years.
We bring dedicated senior partners with unmatched execution experience in potential conflict situations, working seamlessly with industry experts. Our advice is anchored in deep financial and sector knowledge, delivered with a steadfast commitment to objectivity and independence.
Centerview’s own independent structure reinforces our ability to offer unbiased counsel in complex and high-stakes scenarios. Boards and independent directors trust Centerview to provide clear, impartial guidance that supports sound decision-making and protects shareholder interests.
Recent Transactions
Boston Pharmaceuticals
Announced: Q2 2025
Value: Up to $2.0 billion
Status: Pending
Exclusive financial advisor to Boston Pharmaceuticals on its sale of efimosfermin to GSK
View All
Career Opportunities
At Centerview Partners, our success depends on our people, and we are always looking for talented individuals. Please
let us know
if you would like to learn more about a career at Centerview.
Our Team
Our Partners have worked on many of the largest and most complex transactions and corporate situations around the globe over the course of their careers.
Learn more
about who we are.